Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Life sciences-focused search firm Slone Partners has launched Slone Partners Cybersecurity, a national talent recruitment firm that delivers diverse commercial, operational, and technical cybersecurity specialists and leaders for companies in all business verticals and health systems. The firm is a successor to Wolf Hill Group, which was founded as a joint venture with Slone Partners in 2019. Adam
Life sciences-focused search firm Slone Partners has placed Patrick Genestin as chief business officer at 1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics. “Patrick Genestin is an extremely accomplished, passionate, and respected business leader with a penchant for establishing strategic partnerships, attracting new investment,
Life sciences-focused search firm Slone Partners has placed Doug Lawrence as the new chief executive officer of Hygieia, a digital therapeutics company for insulin therapy. “Doug Lawrence is an extraordinarily driven and accomplished diabetes technology leader with a track record of tremendous success leading global business operations,” said Tara Kochis, president of Slone Partners. “He brings tremendous experience and a
Life sciences-focused search firm Slone Partners has named Melissa Hurst as practice leader for healthcare. “Melissa Hurst is a very smart, talented, and experienced leader in healthcare executive search,” said Leslie Loveless, CEO of Slone Partners. “As practice leader, she will drive our strategic efforts to build out Slone Partners’ healthcare client base and expand our partnerships with some
New CEO brings more than 30 years of medical technology leadership to new role SOUTH RIDING, VA. – August 26, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Doug Lawrence as Chief Executive Officer (CEO) at Hygieia, a leading digital therapeutics company for insulin therapy, where he
SOUTH RIDING, VA. – August 18, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Melissa Hurst has been named Practice Leader for Healthcare. With her extensive background in healthcare executive search, Hurst will focus on expanding the company’s client base with hospitals, health systems, and academic centers. She
SOUTH RIDING, VA. – August 16, 2022 – Diversity, Equity, and Inclusion (DEI) Strategies by Slone Partners has received Approved Provider (AP) accreditation from the HR Certification Institute® (HRCI®). As an AP, DEI Strategies at Slone Partners will offer quality public continuing education events/training and private engagements that are pre-approved based on aligning with HRCI’s Exam Content Outlines. The events meeting those outlines
SOUTH RIDING, VA. – August 8, 2022 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Michael Shaffer as Chief Financial Officer (CFO) at Renovo Solutions, a leading healthcare technology management company that recently received a growth equity investment from Water Street Healthcare Partners. Shaffer
SOUTH RIDING, VA. – August 1, 2022 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Thomas Schlumpberger as Chief Executive Officer (CEO) and member of the Board of Directors at Nanomix, a leader in mobile, affordable, point-of-care (POC) diagnostics. Schlumpberger is a recognized
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025